Emerald Health Therapeutics, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was CAD 2.255 million compared to CAD 2.889 million a year ago. Operating loss was CAD 4.526 million compared to CAD 6.870 million a year ago. Net loss was CAD 2.894 million compared to CAD 4.734 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.03 a year ago.